Dudley McCaw, DVM, DAVCIM (IM and Onco) Professor, Oncology Phone: 785-532-5690 E-mail: dmccaw@vet.k-state.edu

Professional Training:

• Bachelor of Science: University of Illinois
• DVM: University of Illinois
• Residency: Michigan State University – Internal Medicine University of Missouri – Oncology

Teaching:

• Medicine II (3rd year)
• Clinical Oncology (4th year)

Research:

• Analysis of proteins involved in canine lymphoma
• Efficacy of adjuvant mitoxantrone chemotherapy for the treatment of canine bladder tumors
• Therapeutic strategies for oral melanoma in dogs
• Oncology and treatment of naturally occurring diseases
• PDT (photodynamic therapy) for canine and feline neoplasms
• Chemotherapeutic treatment of canine mast cell tumors

Clinical:

Dr. McCaw’s clinical interests are canine and feline oncology.

Selected Publications:

• McCaw DL, Chan AS, Stegner AL, Brian Mooney B, Bryan JN, Turnquist SE, Henry CJ, Alexander H, Alexander S. Proteomics of canine lymphoma identifies potential cancer specific protein markers. Clinical Cancer Research 2007;13:2496-2503.
• Guiliano EA, McCaw DL, MacDonald PJ, Johnson PJ, Klauss G, Ford MM, Scotty NC, Galle LE, Moore CP. Photodynamic Therapy for the Treatment of Periocular Squamous Cell Carcinoma in Horses. Association for Research in Vision and Ophthalmology / Invest Ophthalmol Vis Sci, 2004,45:E-3566.
• Guiliano EA, McCaw DL, MacDonald PJ, Johnson PJ, Klauss G, Ford MM, Scotty NC, Galle LE, Moore CP. Photodynamic Therapy for the Treatment of Periocular Squamous Cell Carcinoma in Horses. Proc. American College of Veterinary Ophthalmologists, 34th Annual Meeting, Coeur D’ Alene, Idaho, 2003, page 69.
• Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA, Higginbotham ML, Chun R. Clinical Evaluation of Mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Cancer Res 2003; 9:906-11.